Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Catheter Precision (VTAK) Gross Margin (2017 - 2025)

Catheter Precision (VTAK) has disclosed Gross Margin for 9 consecutive years, with 91.6% as the latest value for Q4 2025.

  • Quarterly Gross Margin fell 102.0% to 91.6% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 92.31% through Dec 2025, up 231.0% year-over-year, with the annual reading at 92.31% for FY2025, 231.0% up from the prior year.
  • Gross Margin for Q4 2025 was 91.6% at Catheter Precision, roughly flat from 92.04% in the prior quarter.
  • The five-year high for Gross Margin was 95.49% in Q3 2023, with the low at 11075.0% in Q1 2021.
  • Average Gross Margin over 5 years is 1325.52%, with a median of 90.59% recorded in 2024.
  • The sharpest move saw Gross Margin tumbled -1105972bps in 2021, then surged 1011944bps in 2022.
  • Over 5 years, Gross Margin stood at 6840.0% in 2021, then soared by 82bps to 1220.0% in 2022, then surged by 108bps to 94.53% in 2023, then fell by -2bps to 92.62% in 2024, then fell by -1bps to 91.6% in 2025.
  • According to Business Quant data, Gross Margin over the past three periods came in at 91.6%, 92.04%, and 93.4% for Q4 2025, Q3 2025, and Q2 2025 respectively.